BriaCell Therapeutics Stock Forecast for 2023 - 2025 - 2030
Updated on 05/02/2024
BriaCell Therapeutics Stock Forecast and Price Target
BriaCell Therapeutics's stock price reaches the average target of C$1.48 by 2025 as expected recently by notable experts, there would be a potential downside of approximately -48.79% from the last closing price in May, 2024. This possible increase is based on a high estimate of C$1.66 and a low estimate of C$1.32. Even if you're not interested in BCT stock, you may be interested in its competitors.
-48.79% Downside
BriaCell Therapeutics Fair Value Forecast for 2023 - 2025 - 2030
In the last zero years, BriaCell Therapeutics's Price has seen an increase, rising from C$0.00 to C$0.00. This represents a growth of 100.00%. Analysts predict that BriaCell Therapeutics's Fair Value will increase in the upcoming year, reaching C$2.96. This would represent an increase of 100.00%. Over the next seven years, experts predict that BriaCell Therapeutics's Fair Value will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| XENE Stock Forecast | Xenon Pharmaceuticals | Buy |
11
|
$42.49 | Buy/Sell | $51.46 | 41.21% |
| AUPH Stock Forecast | Aurinia Pharmaceuticals | Outperform |
6
|
$5.20 | Buy/Sell | $13.21 | 92.31% |
| ZYME Stock Forecast | Zymeworks | Outperform |
7
|
$8.76 | Buy/Sell | $13.52 | 59.82% |
| EPIX Stock Forecast | ESSA Pharma | Buy |
5
|
$6.62 | Buy/Sell | $26.91 | 257.85% |
| ACHF.F Stock Forecast | Arch Biopartners | - |
4
|
$1.12 | Buy/Sell | $0.00 | -100.00% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CRDL Stock Forecast | Cardiol Therapeutics | Outperform |
7
|
C$2.84 | Buy/Sell | C$4.50 | 58.45% |
| SVA Stock Forecast | Sernova | Outperform |
5
|
C$0.43 | Buy/Sell | C$4.07 | 667.44% |
| MIST Stock Forecast | Milestone Pharmaceuticals | Outperform |
4
|
$1.60 | Buy/Sell | $10.80 | 337.50% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| MDNA Stock Forecast | Medicenna Therapeutics | Buy |
0
|
C$2.31 | Buy/Sell | C$6.30 | 203.03% |
| PMN Stock Forecast | ProMIS Neurosciences | Buy |
6
|
$1.92 | Buy/Sell | $18.49 | 526.04% |
| IPA Stock Forecast | ImmunoPrecise Antibodies | Buy |
9
|
$1.25 | Buy/Sell | $7.00 | 460.00% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| APS Stock Forecast | Aptose Biosciences | Outperform |
9
|
C$1.66 | Buy/Sell | C$11.08 | -100.00% |
| MBX Stock Forecast | Microbix Biosystems | Buy |
0
|
C$0.43 | Buy/Sell | C$0.00 | 86.05% |
| IBT Stock Forecast | IBEX Technologies | - |
0
|
C$1.44 | Buy/Sell | C$0.70 | -100.00% |
BriaCell Therapeutics EBITDA Forecast for 2023 - 2025 - 2030
BriaCell Therapeutics's EBITDA has grown in the last three years, jumping from C$-4.82M to C$-23.26M – an increase of 382.57%. For the following year, the 0 analysts predict that BriaCell Therapeutics's EBITDA will drop by 39.84%, reaching C$-13.99M. In 2030, the professionals' prediction is that BCT's EBITDA will decrease by 34.63%, reaching C$-15.20M.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| TBPM.Q Stock Forecast | Tetra Bio-Pharma | - |
0
|
$0.00 | Buy/Sell | $0.00 | 0.00% |
| BU Stock Forecast | Burcon NutraScience | - |
0
|
C$0.29 | Buy/Sell | C$2.50 | -100.00% |
| COV Stock Forecast | Covalon Technologies | - |
0
|
C$1.01 | Buy/Sell | C$0.00 | -100.00% |
BriaCell Therapeutics EBIT Forecast for 2023 - 2025 - 2030
In the last three years, BriaCell Therapeutics's EBIT has increased by 380.79%, going from C$-4.84M to C$-23.27M. In the next year, analysts are expecting an increase in EBIT, predicting it will reach C$-34.30M – an increase of 47.40%. According to professionals, by 2030, BriaCell Therapeutics's EBIT will have decreased by 167.04%, falling down to C$15.60M.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 20B Stock Forecast | Biomark Diagnostics | - |
0
|
0.17€ | Buy/Sell | 0.00€ | -100.00% |
| SBM Stock Forecast | Sirona Biochem | - |
-10
|
C$0.06 | Buy/Sell | C$0.95 | -100.00% |
| EDSA Stock Forecast | Edesa Biotech | Buy |
-17
|
$4.45 | Buy/Sell | $36.67 | 371.91% |
BriaCell Therapeutics EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last zero years, BriaCell Therapeutics's EPS has seen an increase, rising from C$0.00 to C$0.00. This represents a growth of 100.00%. Analysts predict that BriaCell Therapeutics's EPS will increase in the upcoming year, reaching C$-0.79. This would represent an increase of 100.00%. Over the next seven years, experts predict that BriaCell Therapeutics's EPS will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| RVX Stock Forecast | Resverlogix | - |
0
|
C$0.07 | Buy/Sell | C$0.00 | -100.00% |
| MVMD Stock Forecast | Mountain Valley MD Holdings | - |
-16
|
C$0.05 | Buy/Sell | C$0.00 | -100.00% |
| KNE Stock Forecast | Kane Biotech | - |
0
|
C$0.13 | Buy/Sell | C$0.00 | -100.00% |
Site Navigation
.jpg)